Thymus and activation-regulated chemokine as a clinical biomarker in atopic dermatitis

Baseline serum TARC levels predict therapy outcome in patients with Hodgkin lymphoma

(2012) Maike Sauer et al.   AMERICAN JOURNAL OF HEMATOLOGY

Long Term Treatment Concepts and Proactive Therapy for Atopic Eczema

(2012) Andreas Wollenberg et al.   Annals of Dermatology

Atopic Dermatitis

(2010) Thomas Bieber   Annals of Dermatology

CCL17/thymus and activation-related chemokine in Churg-Strauss syndrome

(2010) Tomáš Dallos et al.   ARTHRITIS AND RHEUMATISM

Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trials

(2010) J. Schmitt et al.   BRITISH JOURNAL OF DERMATOLOGY

Elevated umbilical cord serum TARC/CCL17 levels predict the development of atopic dermatitis in infancy

(2010) H. Miyahara et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Clinical and Cytological Effects of Pimecrolimus Cream 1% after Resolution of Active Atopic Dermatitis Lesions by Topical Corticosteroids: A Randomized Controlled Trial

(2010) Christine Bangert et al.   DERMATOLOGY

Serum measurement of thymus and activation-regulated chemokine/CCL17 in children with atopic dermatitis: elevated normal levels in infancy and age-specific analysis in atopic dermatitis

(2009) Takao Fujisawa et al.   PEDIATRIC ALLERGY AND IMMUNOLOGY

Epidemiologic risks for food allergy

(2008) Gideon Lack   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY